Captrust Financial Advisors Aerie Pharmaceuticals Inc Transaction History

Captrust Financial Advisors

  • $30.9 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$4.95 - $9.16 $331 - $613
-67 Reduced 13.32%
436 $3,000
Q1 2022

May 16, 2022
BUY
$5.64 - $9.8 $2,836 - $4,929
503 New
503 $5,000
Q4 2021

Feb 14, 2022
SELL
$7.02 - $13.33 $2,639 - $5,012
-376 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$15.16 - $18.97 $5,700 - $7,132
376 New
376 $6,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email